International Journal of Clinical Pharmacy

, Volume 35, Issue 6, pp 1113–1119 | Cite as

Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy

  • Prem Adhien
  • Liset van Dijk
  • Marinke de Vegter
  • Marnix Westein
  • Giel Nijpels
  • Jacqueline G. HugtenburgEmail author
Research Article


Background Interventions aimed to increase adherence to drug treatment usually are not tailored to the needs of individual patients. A modular pharmacy intervention, named ‘Support for Diabetes’, was developed to improve adherence to type 2 diabetes treatment. Objective To evaluate the implementation of a new care intervention by using focus groups including pharmacy teams, and assess patient satisfaction. Setting Community pharmacies in The Netherlands Method The intervention comprises a structured patient interview, an intervention guide and modular interventions tailored to the underlying cause of non-adherence. Feasibility was studied in non-adherent type 2 diabetes mellitus patients, and evaluated by means of focus group interviews with pharmacists and pharmacy technicians. Topics included practicability of the patient selection procedure, patient interviews, materials developed for the intervention and general practitioner (GP) co-operation. Patients’ experiences (n = 36) were assessed by means of a questionnaire. Main outcome measure Feasibility of the intervention and patients’ satisfaction. Results Pharmacists and pharmacy technicians considered the intervention feasible and appreciated its pro-active approach. Involvement of pharmacy technicians proved a stimulating factor. Poor co-operation with GPs and lack of time as well as financial compensation were interfering factors. Patients appreciated the intervention and reported to follow the advice of pharmacists. Conclusion The ‘Support for Diabetes’ intervention is feasible to implement in pharmacy practice. Poor co-operation between pharmacists and GPs and lack of re-imbursement are obstructions for implementation on a wider scale. These issues should receive attention of pharmacists, policymakers and researchers.


Adherence Community pharmacists Diabetes mellitus type-2 Patients’ experience Pharmaceutical care Tailored intervention The Netherlands 



The four pharmacy teams who participated in the study are acknowledged for their co-operation. The authors received unrestricted grants from Apotex, Regifarm, and the Royal Dutch Association for Pharmacy (KNMP).



Conflicts of interest



  1. 1.
    Baan CA, Poos MJJC. Hoe vaak komt diabetes mellitus voor en hoeveel mensen sterven eraan. RIVM 2005.Google Scholar
  2. 2.
    Herings RMC, et al. Chronische Farmacotherapie Voorgezet—Een onderzoek naar de omvang, determinanten en mogelijke economische consequenties van het vroegtijdig afbreken van chronische farmacotherapie, PHARMO Instituut 2002.Google Scholar
  3. 3.
    Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence (Review). Cochrane Database Syst Rev. 2008; (2):CD000011.Google Scholar
  4. 4.
    Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;17:1836–41.CrossRefGoogle Scholar
  5. 5.
    Sabaté E. Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003.Google Scholar
  6. 6.
    Lee WC, Balu S, Cobden D, et al. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface. 2006;19:31–41.PubMedGoogle Scholar
  7. 7.
    Wroe AL. Intentional and unintentional nonadherence: a study of decision-making. J Behav Med. 2002;25:355–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Lehane E, McCarthy G. Intentional and unintentional non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007;44:1468–77.PubMedCrossRefGoogle Scholar
  9. 9.
    Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005;39:1198–203.PubMedCrossRefGoogle Scholar
  10. 10.
    Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55:607–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Hugtenburg JG, Blom ATG, Kisoensingh SU. Initial phase of chronic medication use; patients’ reasons for discontinuation. Br J Clin Pharmacol. 2006;61:352–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Vermeire E, Wens J, Van Royen P, et al. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; (2):1–37.Google Scholar
  13. 13.
    Sluijs EM, Van Dulmen S, Van Dijk L, et al. Patient adherence to medical treatment: a meta review. Utrecht: NIVEL; 2006.Google Scholar
  14. 14.
    Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–67.PubMedCrossRefGoogle Scholar
  15. 15.
    Wong LP. Focus group discussion: a tool for health and medical research. Singapore Med J. 2008;49:256–60.PubMedGoogle Scholar
  16. 16.
    Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320:114–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Herborg H, Haugbølle LS, Sørensen L, et al. Developing a generic, individualised adherence programme for chronic medication users. Pharm Pract. 2008;6:148–57.Google Scholar
  18. 18.
    DiMatteo MR, Haskard-Zolnierek KB, Martin LM. Improving patient adherence: a three-factor model to guide practice. Health Psychol Rev. 2012;6:74–91.CrossRefGoogle Scholar
  19. 19.
    Tinelli M, Ryan M. Bond C Patients’ preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract. 2009;17:275–82.PubMedCrossRefGoogle Scholar
  20. 20.
    Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes (Cochrane Review). Cochrane Lib. 2001; (2):2003.Google Scholar
  21. 21.
    Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30:205–11.PubMedCrossRefGoogle Scholar
  22. 22.
    Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18:63–77.PubMedCrossRefGoogle Scholar
  23. 23.
    Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J. 2003;169:17–22.Google Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2013

Authors and Affiliations

  • Prem Adhien
    • 1
    • 2
  • Liset van Dijk
    • 3
  • Marinke de Vegter
    • 4
  • Marnix Westein
    • 5
  • Giel Nijpels
    • 1
    • 2
  • Jacqueline G. Hugtenburg
    • 2
    • 6
    Email author
  1. 1.Department of General PracticeVU University Medical CenterAmsterdamThe Netherlands
  2. 2.EMGO Institute for Health and Care ResearchVU University Medical CenterAmsterdamThe Netherlands
  3. 3.NIVELUtrechtThe Netherlands
  4. 4.Kring Apotheken NederlandUtrechtThe Netherlands
  5. 5.Royal Dutch Association for PharmacyDen HaagThe Netherlands
  6. 6.Department of Clinical Pharmacology and PharmacyVU University Medical CenterAmsterdamThe Netherlands

Personalised recommendations